Article
Novel engineered chimeric engulfment receptors trigger T-cell effector functions against SIV infected CD4+ T cells
2022-06-25
Abstract excerpt
<h4>ABSTRACT</h4> Adoptive therapy with genetically engineered T cells offers potential for infectious disease treatment in immunocompromised persons. HIV/simian immunodeficiency virus (SIV) infected cells express phosphatidylserine (PS) early post-infection. We tested whether chimeric engulfment receptor (CER) T cells designed to recognize PS-expressing cells could eliminate SIV infected cells. Lentiviral CER co...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1f6c4bf0-0bee-5361-9e4a-2d2f087263e2
- DOI
- 10.1101/2022.06.21.495546
